IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
6.90
-0.15 (-2.13%)
Dec 20, 2024, 4:00 PM EST - Market closed

IGM Biosciences Revenue

IGM Biosciences had revenue of $516.00K in the quarter ending September 30, 2024, with 1.38% growth. This brings the company's revenue in the last twelve months to $2.92M, up 57.64% year-over-year. In the year 2023, IGM Biosciences had annual revenue of $2.13M with 99.25% growth.

Revenue (ttm)
$2.92M
Revenue Growth
+57.64%
P/S Ratio
142.54
Revenue / Employee
$13,027
Employees
224
Market Cap
410.30M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.13M1.06M99.25%
Dec 31, 20221.07M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Organogenesis Holdings 455.04M
Health Catalyst 302.06M
Esperion Therapeutics 295.45M
Tactile Systems Technology 285.05M
Sonida Senior Living 253.20M
Codexis 64.45M
OmniAb 20.41M
Revenue Rankings